Abstract
Prebiotics from algae as a treatment for inflammatory bowel disease The Algae4IBD project is studying the potential of probiotics and algae-derived prebiotics as a treatment for inflammatory bowel disease. Inflammatory bowel disease (IBD) is a term used to describe a group of autoimmune disorders, including Crohn's disease and ulcerative colitis, which cause long-term inflammation in the gut. Symptoms such as persistent diarrhoea, abdominal pain and rectal bleeding can be distressing and the impact on patient quality of life is often substantial. IBD already affects millions of patients worldwide, and this number is expected to grow significantly in the coming decades. While traditionally a disease of western industrialised nations, IBD is now growing in newly industrialised and developing countries, likely reflecting the widespread adoption of a westernised diet.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
